Coagulase-negative staphylococci (CoNS) are the leading cause of late-onset sepsis (LOS) in neonates. Increasing resistance of CoNS to beta-lactams and aminoglycosides has led to widespread use of vancomycin, which in turn may lead to resistance to vancomycin. Thus, combination therapy of LOS has been advocated. We aimed to determine the interaction of oxacillin and gentamicin against CoNS. In 2005, 34 isolates of oxacillin- and gentamicin-resistant CoNS were obtained from blood samples of neonates with LOS. Combination effect was tested using the checkerboard method, E-test with the other antibiotic incorporated in the medium (E-test-1) and two E-test strips placed in a cross-formation (E-test-2). Of 34 isolates 61.8%, 53% and 73.5% revealed synergy or an additive effect when tested by the checkerboard method, E-test-1 and E-test-2, respectively. Results of all three tests were concordant for six (17.6%) isolates, four showing synergy, and two indifference. Our in vitro results support that combination therapy with penicillinase-resistant penicillin and aminoglycoside can be an alternative to vancomycin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/apm.12048 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Antimicrobial Resistance Profiles and Gene Characterization of Recovered from Facial Skin of Healthy Females in Shanghai, China.
Clin Cosmet Investig Dermatol
December 2024
School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, People's Republic of China.
Article Synopsis
- The study aimed to investigate antimicrobial resistance and gene characterization in facial skin samples from healthy women in Shanghai, China.
- Researchers collected samples from 107 females, isolating 94 unique bacterial strains, and tested their resistance to various antibiotics using standardized methods.
- Notable findings included a 23.4% resistance rate to oxacillin (indicating methicillin resistance), with several other antibiotics showing varying degrees of resistance, highlighting potential public health risks due to the prevalence of diverse resistance and virulence genes.
Epidemiological and Clinical Insights into : A Six-Year Study on Age, Antibiotics, and Specimens.
Int J Gen Med
December 2024
Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Background: This six-year retrospective study provides an in-depth analysis of the epidemiological and clinical patterns associated with () infections, focusing on age distribution, antibiotic resistance profiles, and specimen types.
Aim: The research examines the incidence and characteristics of non-Multi-Drug Resistant (non-MDR) and Multi-Drug Resistant (MDR) strains by reviewing patient records from January 2016 to December 2022.
Methods: Through a statistical analysis, the study highlights the incidence rates across diverse age groups and explores the impact of antibiotic treatment regimens on infection outcomes.
Anti- Activity of Volatile Phytochemicals and Their Combinations with Conventional Antibiotics Against Methicillin-Susceptible (MSSA) and Methicillin-Resistant (MRSA) Strains.
Antibiotics (Basel)
October 2024
Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovica 3, 21000 Novi Sad, Serbia.
Background: MSSA and MRSA strains are challenging human pathogens that can develop resistance to antibiotics, highlighting the need for alternative antimicrobial agents. Plant metabolites, particularly volatile phytochemicals, may offer promising antimicrobial properties. The aim was to evaluate the antimicrobial and antibiofilm efficacy of various commercial volatile phytochemicals from the terpene and terpenoid groups against reference MSSA and MRSA strains, focusing on synergistic effects in both binary combinations and combinations with antibiotics.
View Article and Find Full Text PDFProfile of antimicrobial use and potential use of the defined daily dose in neonatology.
Sci Rep
October 2024
Department of Life Sciences (DCV), State University of Bahia (UNEB), Campus I, 2555 Silveira Martins Street, Cabula, Salvador, 41150-000, Bahia, Brazil.
One of the measures for monitoring microbial resistance is the calculation of the defined daily dose of antimicrobial agents. For this calculation, the weight of an adult of 70 kg is used as a standard, so that application in neonatology is not possible. The aim of this study is to describe the use profile and calculate the defined daily dose (DDD) of antimicrobials in a neonatal intensive care unit (NICU) of a public hospital in the interior of Bahia, Brazil.
View Article and Find Full Text PDFPhenotypic bacterial epidemiology and antimicrobial resistance profiles in neonatal sepsis at Jimma medical center, Ethiopia: Insights from prospective study.
PLoS One
September 2024
Department of Medical Laboratory Sciences, Jimma University, Jimma, Oromia, Ethiopia.
Background: Epidemiological profiles and the rundown crisis of antimicrobial resistance from bacterial isolates in neonatal sepsis compel regular surveillance to enhance data-driven decision-making. Accordingly, this study aimed to assess the phenotypic epidemiology and antimicrobial resistance profiles of bacteria isolated from clinically suspected neonatal sepsis in Ethiopia.
Methods: A total of 342 neonates suspected of clinical sepsis were randomly included in a prospective observational study conducted at the neonatal intensive care unit (NICU) of Jimma medical center (JMC) from May 2022 to July 2023.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!